From Cruise Control to Self-Driving Adaptive System: Intelligent Closed-Loop Neuromodulation
Part of Plenary II: Neuromodulation 2035: Precision, Prediction, and Personalization
Details
- Date
- Friday, January 22, 2027
- Time
- 1:35 PM – 1:52 PM
- Session type
- Plenary
- Schedule
- See this day
About
By 2035, neuromodulation is expected to evolve from static, anatomy-based stimulation toward AI-driven closed-loop systems, hybrid multisite targeting, and network-guided personalization. This session will examine how advances in computational modeling, digital biomarkers, and multimodal stimulation strategies may redefine patient selection, programming, durability of response, and value-based care in chronic pain management.
Presenters
-
Robert M. Levy, MD, PhD
Editor in Chief, Neuromomodulation
International Neuromodulation Society · Florida
Robert M. Levy, M.D., Ph.D., is an internationally recognized neurosurgeon, and currently holds the position of Editor-in-Chief of Neuromodulation: Technology at the Neural Interface. He is Past-President of the International Neuromodulation Society (INS). He earned his medical degree and Ph.D. in neurosciences from Stanford University Medical School. He performed post-doctoral fellowships at Stanford University and UCSF.
During his academic career, he has been a tenured full Professor of Neurosurgery, Physiology and Radiation Oncology at the Feinberg School Medicine at Northwestern University. He has served as Professor and Chairman of the Department of Neurological Surgery and Co-Director of the University of Florida Health Sciences in Jacksonville, Florida. He most recently served as the Founding Director of the Marcus Neuroscience Institute and Director of the Harvey Sandler Center for Neurosurgery in Boca Raton, Florida. He has been the recipient of many national and international honors and awards and has been listed in the Best Doctors in America. He has authored several textbooks and published over 300 peer-reviewed journal articles. His current research involves novel applications of neurostimulation and targeted drug delivery to the brain. In addition, he has assisted with the design and implementation of multiple neuromodulation technologies and devices.